Taxotere, Cisplatin and Irinotecan (CPT-11) for Esophagogastric Cancer

Clinical trial NCT00165464 · COMPLETED

Trial details

NCT number: NCT00165464
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Esophageal Cancer Gastric Cancer GE Junction Cancer

Start date: 2001-08-01
Primary completion: 2005-03-01
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.